About
MRNA-based therapies, vaccines
Areas of Focus
Categories
VaccineGene Therapy, RNA & Peptide Therapy
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
123
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07059767Lead Sponsor
Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge
PHASE2Recruiting
50 participants
Started: Jun 24, 2025 · Completed: Jun 30, 2026
NCT07055321Lead Sponsor
A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants
PHASE1Completed
73 participants
Started: Nov 29, 2023 · Completed: Jul 8, 2024
Locations (1)
Headquarters
Planegg, Germany
Map
Loading map...